BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8508955)

  • 1. Functional display of human plasminogen-activator inhibitor 1 (PAI-1) on phages: novel perspectives for structure-function analysis by error-prone DNA synthesis.
    Pannekoek H; van Meijer M; Schleef RR; Loskutoff DJ; Barbas CF
    Gene; 1993 Jun; 128(1):135-40. PubMed ID: 8508955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective screening of a large phage display library of plasminogen activator inhibitor 1 mutants to localize interaction sites with either thrombin or the variable region 1 of tissue-type plasminogen activator.
    van Meijer M; Roelofs Y; Neels J; Horrevoets AJ; van Zonneveld AJ; Pannekoek H
    J Biol Chem; 1996 Mar; 271(13):7423-8. PubMed ID: 8631768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-density mutagenesis by combined DNA shuffling and phage display to assign essential amino acid residues in protein-protein interactions: application to study structure-function of plasminogen activation inhibitor 1 (PAI-I).
    Stoop AA; Jespers L; Lasters I; Eldering E; Pannekoek H
    J Mol Biol; 2000 Sep; 301(5):1135-47. PubMed ID: 10966811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator.
    Horn IR; van den Berg BM; Moestrup SK; Pannekoek H; van Zonneveld AJ
    Thromb Haemost; 1998 Nov; 80(5):822-8. PubMed ID: 9843178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different structural requirements for plasminogen activator inhibitor 1 (PAI-1) during latency transition and proteinase inhibition as evidenced by phage-displayed hypermutated PAI-1 libraries.
    Stoop AA; Eldering E; Dafforn TR; Read RJ; Pannekoek H
    J Mol Biol; 2001 Jan; 305(4):773-83. PubMed ID: 11162091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High level expression of recombinant plasminogen activator inhibitor-1 in Escherichia coli and generation of its mutants involving Asp125, Glu128 and Glu130.
    Sui GC; Sun H; Zhang M; Hu MH
    Biochem Mol Biol Int; 1997 Jul; 42(3):621-9. PubMed ID: 9247720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering plasminogen activator inhibitor 1 mutants with increased functional stability.
    Lawrence DA; Olson ST; Palaniappan S; Ginsburg D
    Biochemistry; 1994 Mar; 33(12):3643-8. PubMed ID: 8142362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification of active human plasminogen activator inhibitor 1 from Escherichia coli. Comparison with natural and recombinant forms purified from eucaryotic cells.
    Lawrence D; Strandberg L; Grundström T; Ny T
    Eur J Biochem; 1989 Dec; 186(3):523-33. PubMed ID: 2514093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of peptides that bind to plasminogen activator inhibitor 1 (PAI-1) using random peptide phage-display libraries.
    Gårdsvoll H; van Zonneveld AJ; Holm A; Eldering E; van Meijer M; Danø K; Pannekoek H
    FEBS Lett; 1998 Jul; 431(2):170-4. PubMed ID: 9708896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-level synthesis of biologically active human plasminogen activator inhibitor type 1 (PAI-1) in Escherichia coli.
    Sisk WP; Davis GL; Kingsley D; Chiu AT; Reilly TM
    Gene; 1990 Dec; 96(2):305-9. PubMed ID: 2269442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional effects of single amino acid substitutions in the region of Phe113 to Asp138 in the plasminogen activator inhibitor 1 molecule.
    Sui GC; Wiman B
    Biochem J; 1998 Apr; 331 ( Pt 2)(Pt 2):409-15. PubMed ID: 9531478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-level expression of active human plasminogen activator inhibitor type 1 (PAI-1) in E. coli.
    Zhou A; Pei Y; Wu H; Dong X; Xu X
    Biochem Mol Biol Int; 1996 May; 39(2):235-42. PubMed ID: 8799449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and characterization of recombinant porcine plasminogen activator inhibitor-1.
    Bijnens AP; Knockaert I; Cousin E; Kruithof EK; Declerck PJ
    Thromb Haemost; 1997 Feb; 77(2):350-6. PubMed ID: 9157595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ovine plasminogen activator inhibitors type 1 and type 2 cDNAs: molecular cloning, characterization and expression in various tissues.
    Theodorou G; Bizelis I; Rogdakis E; Politis I
    Gene; 2010 Apr; 454(1-2):20-30. PubMed ID: 20114071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of storage granule protein-23. A novel protein identified by phage display technology and interaction with type I plasminogen activator inhibitor.
    Lang IM; Chuang TL; Barbas CF; Schleef RR
    J Biol Chem; 1996 Nov; 271(47):30126-35. PubMed ID: 8939962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 19F NMR studies of plasminogen activator inhibitor-1.
    Abbott GL; Blouse GE; Perron MJ; Shore JD; Luck LA; Szabo AG
    Biochemistry; 2004 Feb; 43(6):1507-19. PubMed ID: 14769027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex to the endocytosis receptors alpha2-macroglobulin receptor/low-density lipoprotein receptor-related protein and very-low-density lipoprotein receptor involves basic residues in the inhibitor.
    Rodenburg KW; Kjoller L; Petersen HH; Andreasen PA
    Biochem J; 1998 Jan; 329 ( Pt 1)(Pt 1):55-63. PubMed ID: 9405275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Separation of active and inactive forms of recombinant human plasminogen activator inhibitor type 1 (PAI-1) expressed in Chinese hamster ovary cells: comparison with native human PAI-1.
    Strömqvist M; Andersson JO; Boström S; Deinum J; Ehnebom J; Enquist K; Johansson T; Hansson L
    Protein Expr Purif; 1994 Aug; 5(4):309-16. PubMed ID: 7950376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renaturation, purification, and characterization of human plasminogen activator inhibitor type 2 (PAI-2) accumulated at high level in Escherichia coli.
    Zhou A; Jiang X; Dou F; Zhu D; Xu X
    J Biochem; 1997 May; 121(5):930-4. PubMed ID: 9192735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
    Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.